Cargando…
Bioactive Ingredients in Chinese Herbal Medicines That Target Non-coding RNAs: Promising New Choices for Disease Treatment
Chinese herbal medicines (CHMs) are widely used in China and have long been a powerful method to treat diseases in Chinese people. Bioactive ingredients are the main components extracted from herbs that have therapeutic properties. Since artemisinin was discovered to inhibit malaria by Nobel laureat...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537929/ https://www.ncbi.nlm.nih.gov/pubmed/31178721 http://dx.doi.org/10.3389/fphar.2019.00515 |
_version_ | 1783422097863737344 |
---|---|
author | Dong, Yan Chen, Hengwen Gao, Jialiang Liu, Yongmei Li, Jun Wang, Jie |
author_facet | Dong, Yan Chen, Hengwen Gao, Jialiang Liu, Yongmei Li, Jun Wang, Jie |
author_sort | Dong, Yan |
collection | PubMed |
description | Chinese herbal medicines (CHMs) are widely used in China and have long been a powerful method to treat diseases in Chinese people. Bioactive ingredients are the main components extracted from herbs that have therapeutic properties. Since artemisinin was discovered to inhibit malaria by Nobel laureate Youyou Tu, extracts from natural plants, particularly bioactive ingredients, have aroused increasing attention among medical researchers. The bioactive ingredients of some CHMs have been found to target various non-coding RNA molecules (ncRNAs), especially miRNAs, lncRNAs, and circRNAs, which have emerged as new treatment targets in numerous diseases. Here we review the evidence that, by regulating the expression of ncRNAs, these ingredients exert protective effects, including pro-apoptosis, anti-proliferation and anti-migration, anti-inflammation, anti-atherosclerosis, anti-infection, anti-senescence, and suppression of structural remodeling. Consequently, they have potential as treatment agents in diseases such as cancer, cardiovascular disease, nervous system disease, inflammatory bowel disease, asthma, infectious diseases, and senescence-related diseases. Although research has been relatively limited and inadequate to date, the promising choices and new alternatives offered by bioactive ingredients for the treatment of the above diseases warrant serious investigation. |
format | Online Article Text |
id | pubmed-6537929 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65379292019-06-07 Bioactive Ingredients in Chinese Herbal Medicines That Target Non-coding RNAs: Promising New Choices for Disease Treatment Dong, Yan Chen, Hengwen Gao, Jialiang Liu, Yongmei Li, Jun Wang, Jie Front Pharmacol Pharmacology Chinese herbal medicines (CHMs) are widely used in China and have long been a powerful method to treat diseases in Chinese people. Bioactive ingredients are the main components extracted from herbs that have therapeutic properties. Since artemisinin was discovered to inhibit malaria by Nobel laureate Youyou Tu, extracts from natural plants, particularly bioactive ingredients, have aroused increasing attention among medical researchers. The bioactive ingredients of some CHMs have been found to target various non-coding RNA molecules (ncRNAs), especially miRNAs, lncRNAs, and circRNAs, which have emerged as new treatment targets in numerous diseases. Here we review the evidence that, by regulating the expression of ncRNAs, these ingredients exert protective effects, including pro-apoptosis, anti-proliferation and anti-migration, anti-inflammation, anti-atherosclerosis, anti-infection, anti-senescence, and suppression of structural remodeling. Consequently, they have potential as treatment agents in diseases such as cancer, cardiovascular disease, nervous system disease, inflammatory bowel disease, asthma, infectious diseases, and senescence-related diseases. Although research has been relatively limited and inadequate to date, the promising choices and new alternatives offered by bioactive ingredients for the treatment of the above diseases warrant serious investigation. Frontiers Media S.A. 2019-05-21 /pmc/articles/PMC6537929/ /pubmed/31178721 http://dx.doi.org/10.3389/fphar.2019.00515 Text en Copyright © 2019 Dong, Chen, Gao, Liu, Li and Wang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Dong, Yan Chen, Hengwen Gao, Jialiang Liu, Yongmei Li, Jun Wang, Jie Bioactive Ingredients in Chinese Herbal Medicines That Target Non-coding RNAs: Promising New Choices for Disease Treatment |
title | Bioactive Ingredients in Chinese Herbal Medicines That Target Non-coding RNAs: Promising New Choices for Disease Treatment |
title_full | Bioactive Ingredients in Chinese Herbal Medicines That Target Non-coding RNAs: Promising New Choices for Disease Treatment |
title_fullStr | Bioactive Ingredients in Chinese Herbal Medicines That Target Non-coding RNAs: Promising New Choices for Disease Treatment |
title_full_unstemmed | Bioactive Ingredients in Chinese Herbal Medicines That Target Non-coding RNAs: Promising New Choices for Disease Treatment |
title_short | Bioactive Ingredients in Chinese Herbal Medicines That Target Non-coding RNAs: Promising New Choices for Disease Treatment |
title_sort | bioactive ingredients in chinese herbal medicines that target non-coding rnas: promising new choices for disease treatment |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537929/ https://www.ncbi.nlm.nih.gov/pubmed/31178721 http://dx.doi.org/10.3389/fphar.2019.00515 |
work_keys_str_mv | AT dongyan bioactiveingredientsinchineseherbalmedicinesthattargetnoncodingrnaspromisingnewchoicesfordiseasetreatment AT chenhengwen bioactiveingredientsinchineseherbalmedicinesthattargetnoncodingrnaspromisingnewchoicesfordiseasetreatment AT gaojialiang bioactiveingredientsinchineseherbalmedicinesthattargetnoncodingrnaspromisingnewchoicesfordiseasetreatment AT liuyongmei bioactiveingredientsinchineseherbalmedicinesthattargetnoncodingrnaspromisingnewchoicesfordiseasetreatment AT lijun bioactiveingredientsinchineseherbalmedicinesthattargetnoncodingrnaspromisingnewchoicesfordiseasetreatment AT wangjie bioactiveingredientsinchineseherbalmedicinesthattargetnoncodingrnaspromisingnewchoicesfordiseasetreatment |